“…Concerning the primary outcomes of the study, there was no evidence of a difference when comparing HPV-positive (HPV+) women with HPV-negative (HPV-) women regarding live birth or ongoing pregnancy (RR, 1.16 (95% CI, 0.88-1.53); six studies, 983 participants; I 2 = 0%, very low-quality evidence) 6,[20][21][22][23][24] and rate of miscarriage per clinical pregnancy (RR, 1.58 (95% CI, 0.93-2.69); six studies, 290 participants; I 2 = 8%, very low-quality evidence) 6,[20][21][22][23][24] (Tables 1, 2 and Figure 2). Concerning the secondary outcomes of the study, there was no evidence of a difference when comparing HPV+ women with HPV-women regarding clinical pregnancy (RR, 1.06 (95% CI, 0.74-1.54); eight studies, 1173 participants; I 2 = 61%, very low-quality evidence) 6,7,[19][20][21][22][23][24] , positive pregnancy test (RR, 0.90 (95% CI, 0.62-1.30); six studies, 1464 participants; I 2 = 57%, very low-quality evidence) 7,[19][20][21]24,26 and ectopic pregnancy rate (RR, 0.54 (95% CI, 0.12-2.48); two studies, 148 participants; I 2 = 0%, very low-quality evidence) 21,24 (Tables 1, 2 and Figure 2).…”